Newcastle
Oxford
Birmingham
Holbæk Hospital, and Faculty of Health, University of Southern Denmark, Holbæk, Denmark
Tue 11 12:30
S1.3
Secondary disorders: Effects of Glucocorticoid treatment on bone
Holbæk Hospital, and Faculty of Health, University of Southern Denmark, Holbæk, Denmark
Leiden, The Netherlands
Mon 10 10:15
WS2.2
Parathyroid disorders in pregnancy
Leiden, The Netherlands
London
USA
Wed 12 11:40
University of Oslo, Oslo, Norway
Wed 12
S7.2
Estrogen and the ageing brain
University of Oslo, Oslo, Norway
Cochin Hospital, Paris, France
Wed 12 09:35
S6.2
The multiple facets of Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH)
Cochin Hospital, Paris, France
Harvard Medical School, Boston, USA
Liverpool
Wed 12 10:05
S4.3
Managing pituitary disease in transition
Liverpool
University of Birmingham, Birmingham, UK
Florence, Italy
Wed 12 11:40
Sunderland, UK
Tue 11 17:45
HDI1.4
How Do I optimise Lipid therapy in patients with Atherosclerotic Cardiovascular Disease (ASCVD)?
Sunderland, UK
Guy's and St Thomas' Hospital, London, UK
Mon 10 10:15
EE1.2
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Tue 11 14:20
MTE3
Adrenal tumours in children, adolescents and during transition: update on management
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
University of Edinburgh, Edinburgh, UK
Tue 11 08:50
ER1.2
Emerging Researcher Lecture (Clinical Lecture): Targeting human brown adipose tissue to improve cardiometabolic health
University of Edinburgh, Edinburgh, UK
King's College London, London, UK
Tue 11 17:00
HDI1.1
Institute of Metabolic Science, Cambridge, UK
Wed 12 11:40
Mechanisms of Cancer Cachexia
Institute of Metabolic Science, Cambridge, UK
UK
Tue 11 11:30
S1.1
Secondary disorders: Effects of Diabetes on the Bones
UK
University Hospital, Würzburg, Germany
Mon 10 13:25
PL1
University of Exeter, Exeter, UK
University of Leeds, Leeds, UK
Birmingham
University of Cambridge, Cambridge, UK
Queen Elizabeth University Hospital, Glasgow, UK
Mon 10 09:10
WIN1
Israel
Wed 12 09:35
S4.2
Medical treatment of non-functioning pituitary adenoma
Israel
Imperial, UK
Tue 11 12:00
S3.2
Extracellular vesicles from the peri-prostatic adipose tissue from obese, but not lean, men promotes prostate cancer aggressivity
Imperial, UK
Nuffield Department of Women’s & Reproductive Health, University of Oxford, Oxford, United Kingdom
Mon 10 09:45
WS2.1
Calcium physiology in pregnancy and lactation
Nuffield Department of Women’s & Reproductive Health, University of Oxford, Oxford, United Kingdom
London, UK
University of Oxford, Oxford, UK
Mon 10 09:45
WS1.1
Single-molecule to animal
University of Oxford, Oxford, UK
Belfast, Ireland
Wed 12 15:20
HDI2.3
St. Mary's, London, UK
Wed 12 15:05
HDI2.2
France
Wed 12 09:05
S4.1
Mechanisms of GIP responsiveness in pituitary and adrenal tumours
France
San Francisco, USA
Tue 11 18:00
Brainstem circuits regulating appetite suppression
San Francisco, USA
Northampton, UK
Tue 11 17:00
Hormonal regulation of parental behaviour
Northampton, UK
Cologne, Germany
Tue 11 17:30
How the lateral hypothalamus balances nutrition with "social" life
Cologne, Germany
Harvard, USA
Wed 12 09:35
S5.2
Identifying druggable targets in anaplastic thyroid cancer
Harvard, USA
University Hospital Geneva , Geneva, Switzerland
Wed 12 10:05
S5.3
Overview of recent thyroid cancer trials
University Hospital Geneva , Geneva, Switzerland
Newcastle, UK
Wed 12 15:35
HDI2.4
How do I investigate and manage hypophosphataemia without hyperparathyroidism?
Newcastle, UK
Dundee, UK
Wed 12 14:50
FN1.1
Wellcome Sanger Institute, Cambridge, UK
Tue 11 08:30
ER1.1
Emerging Researcher Lecture (Science Lecture): A developmental cell atlas of the human thyroid gland
Wellcome Sanger Institute, Cambridge, UK
Guys & St Thomas’s Hospital and King’s College London, London, UK
Wed 12 08:30
OCP2
Title TBC
Guys & St Thomas’s Hospital and King’s College London, London, UK
Cedars-Sinai Medical Center, Los Angeles CA , USA
Mon 10 17:10
PL4
Growth Hormone, DNA Damage and Cancer
Cedars-Sinai Medical Center, Los Angeles CA , USA
University of Edinburgh Medical School, Edinburgh, UK
Tue 11 11:30
S3.1
Adipocytes show metabolic reprogramming in response to hypoxia to drive cancer cell proliferation
University of Edinburgh Medical School, Edinburgh, UK
Royal Marsden Hospitals, London, UK
Wed 12 14:50
HDI2.1
How do I manage thyroid pathology after irradiation for other head and neck cancers?
Royal Marsden Hospitals, London, UK
Coventry University, Coventry, UK
Mon 10 17:40
D1.1
(AGAINST) - HRT should be used by default for the primary prevention of disease in menopausal women
Coventry University, Coventry, UK
Imperial College London, London, UK
Mon 10 10:45
WS1.3
Super-resolution ultrasound
Imperial College London, London, UK
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Tue 11 14:20
MTE2
Treatment resistant prolactinomas
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Newcastle upon Tyne , UK
Wed 12
MTE5
Advances in medical therapy for Graves' ophthalmopathy
Newcastle upon Tyne , UK
University of Sheffield, Sheffield, UK
Wed 12 09:05
S6.1
Co-morbidities and mortality associated with mild autonomous cortisol excess (MACS)
University of Sheffield, Sheffield, UK
Dublin, Ireland
Tue 11 07:55
Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
Dublin, Ireland
Oxford Centre for Diabetes and Endocrinology , Oxford, UK
Wed 12 15:50
HDI2.5
How do I manage thromboprophylaxis in Cushings?
Oxford Centre for Diabetes and Endocrinology , Oxford, UK
Newcastle University, Newcastle, UK
Wed 12 15:50
FN1.3
Spotting the chaff in the wheat: paper mills and more
Newcastle University, Newcastle, UK
London
Department of Metabolism and Systems Science, University of Birmingham, Birmingham, UK
Tue 11 17:30
HDI1.3
How do I assess and manage HPA axis suppression from exogenous glucocorticoids?
Department of Metabolism and Systems Science, University of Birmingham, Birmingham, UK
Lille, France
Wed 12 09:05
S7.1
GnRH and cognition (DownsSyndrome)
Lille, France
Newcastle University, Newcastle, UK
Mon 10 18:00
D1.2
(FOR) - HRT should be used by default for the primary prevention of disease in menopausal women
Newcastle University, Newcastle, UK
Edinburgh, UK
Mon 10 10:45
WS2.3
Pregnancy Associated Osteoporosis
Edinburgh, UK
Newcastle
Tue 11 17:15
HDI1.2
University of Birmingham, Birmingham, United Kingdom
Wed 12 10:05
S6.3
Prognostication in adrenocortical carcinoma
University of Birmingham, Birmingham, United Kingdom
Cambridge Neuroscience, Cambridge, United Kingdom
Tue 11 09:30
PL5
Title TBC
Cambridge Neuroscience, Cambridge, United Kingdom
University of Cambridge, Cambridge, UK
University of Birmingham, Birmingham, UK
Tue 11 10:55
NKM1
Adrenal Insufficiency: a nurse perspective from novice to expert
University of Birmingham, Birmingham, UK
Institute of Metabolic Science, Cambridge, UK
Tue 11 18:00
LE1.3
University College London Hospital, London, UK
Tue 11 08:10
Birmingham
Wed 12 09:05
S5.1
University of Edinburgh, Edinburgh, UK
Mon 10 10:15
WS1.2
PET
University of Edinburgh, Edinburgh, UK
Cardiff University, Cardiff, UK
University of Cambridge, Cambridge, UK
Oxford University Hospitals NHS Trust, Oxford, UK
Tue 11 14:20
MTE1
Best Practice in Managing Turners Syndrome
Oxford University Hospitals NHS Trust, Oxford, UK
London
Tue 11 12:30
S2.3
Finland
Tue 11 11:30
S2.1
Netherlands Cancer Institute, Amsterdam
Tue 11 12:30
S3.3
How caloric restriction can mimic the effects of endocrine therapies in breast cancer
Netherlands Cancer Institute, Amsterdam
Workshop
0
Oral
14
Expert
14
Plenary
9
Catering and Social
10
Nurse
3
Other
14
Symposium
22
No Session Type
3
Mon 10 09:10
WIN1
Mon 10 17:40
D1.1
(AGAINST) - HRT should be used by default for the primary prevention of disease in menopausal women
Coventry University, Coventry, UK
Mon 10 18:00
D1.2
(FOR) - HRT should be used by default for the primary prevention of disease in menopausal women
Newcastle University, Newcastle, UK
Tue 11 10:55
NKM1
Adrenal Insufficiency: a nurse perspective from novice to expert
University of Birmingham, Birmingham, UK
Tue 11 14:20
MTE1
Best Practice in Managing Turners Syndrome
Oxford University Hospitals NHS Trust, Oxford, UK
Tue 11 14:20
MTE2
Treatment resistant prolactinomas
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Tue 11 14:20
MTE3
Adrenal tumours in children, adolescents and during transition: update on management
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Wed 12
MTE5
Advances in medical therapy for Graves' ophthalmopathy
Newcastle upon Tyne , UK
Wed 12 11:40
Mechanisms of Cancer Cachexia
Institute of Metabolic Science, Cambridge, UK
Wed 12 11:40
Wed 12 11:40
Mon 10 13:25
PL1
Mon 10 17:10
PL4
Growth Hormone, DNA Damage and Cancer
Cedars-Sinai Medical Center, Los Angeles CA , USA
Tue 11 09:30
PL5
Title TBC
Cambridge Neuroscience, Cambridge, United Kingdom
Tue 11 07:55
Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
Dublin, Ireland
Tue 11 08:10
Tue 11 08:30
ER1.1
Emerging Researcher Lecture (Science Lecture): A developmental cell atlas of the human thyroid gland
Wellcome Sanger Institute, Cambridge, UK
Tue 11 08:50
ER1.2
Emerging Researcher Lecture (Clinical Lecture): Targeting human brown adipose tissue to improve cardiometabolic health
University of Edinburgh, Edinburgh, UK
Mon 10 09:45
WS1.1
Single-molecule to animal
University of Oxford, Oxford, UK
Mon 10 10:15
WS1.2
PET
University of Edinburgh, Edinburgh, UK
Mon 10 10:45
WS1.3
Super-resolution ultrasound
Imperial College London, London, UK
Mon 10 10:15
EE1.2
Mon 10 09:45
WS2.1
Calcium physiology in pregnancy and lactation
Nuffield Department of Women’s & Reproductive Health, University of Oxford, Oxford, United Kingdom
Mon 10 10:15
WS2.2
Parathyroid disorders in pregnancy
Leiden, The Netherlands
Mon 10 10:45
WS2.3
Pregnancy Associated Osteoporosis
Edinburgh, UK
Tue 11 11:30
S1.1
Secondary disorders: Effects of Diabetes on the Bones
UK
Tue 11 12:00
S1.2
Novel aspects of bone-kidney communication
Tue 11 12:30
S1.3
Secondary disorders: Effects of Glucocorticoid treatment on bone
Holbæk Hospital, and Faculty of Health, University of Southern Denmark, Holbæk, Denmark
Tue 11 11:30
S3.1
Adipocytes show metabolic reprogramming in response to hypoxia to drive cancer cell proliferation
University of Edinburgh Medical School, Edinburgh, UK
Tue 11 12:00
S3.2
Extracellular vesicles from the peri-prostatic adipose tissue from obese, but not lean, men promotes prostate cancer aggressivity
Imperial, UK
Tue 11 12:30
S3.3
How caloric restriction can mimic the effects of endocrine therapies in breast cancer
Netherlands Cancer Institute, Amsterdam
Tue 11 11:30
S2.1
Tue 11 12:00
S2.2
Trial updates in human MASLD
Tue 11 12:30
S2.3
Tue 11 17:00
Hormonal regulation of parental behaviour
Northampton, UK
Tue 11 17:30
How the lateral hypothalamus balances nutrition with "social" life
Cologne, Germany
Tue 11 18:00
Brainstem circuits regulating appetite suppression
San Francisco, USA
Tue 11 18:00
LE1.3
Tue 11 17:00
HDI1.1
Tue 11 17:15
HDI1.2
Tue 11 17:30
HDI1.3
How do I assess and manage HPA axis suppression from exogenous glucocorticoids?
Department of Metabolism and Systems Science, University of Birmingham, Birmingham, UK
Tue 11 17:45
HDI1.4
How Do I optimise Lipid therapy in patients with Atherosclerotic Cardiovascular Disease (ASCVD)?
Sunderland, UK
Wed 12 08:30
OCP2
Title TBC
Guys & St Thomas’s Hospital and King’s College London, London, UK
Wed 12 09:05
S4.1
Mechanisms of GIP responsiveness in pituitary and adrenal tumours
France
Wed 12 09:35
S4.2
Medical treatment of non-functioning pituitary adenoma
Israel
Wed 12 10:05
S4.3
Managing pituitary disease in transition
Liverpool
Wed 12 09:05
S5.1
Wed 12 09:35
S5.2
Identifying druggable targets in anaplastic thyroid cancer
Harvard, USA
Wed 12 10:05
S5.3
Overview of recent thyroid cancer trials
University Hospital Geneva , Geneva, Switzerland
Wed 12 09:05
S7.1
GnRH and cognition (DownsSyndrome)
Lille, France
Wed 12
S7.2
Estrogen and the ageing brain
University of Oslo, Oslo, Norway
Wed 12
S7.3
Cognitive effects of androgen deprivation therapy
Wed 12 09:05
S6.1
Co-morbidities and mortality associated with mild autonomous cortisol excess (MACS)
University of Sheffield, Sheffield, UK
Wed 12 09:35
S6.2
The multiple facets of Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH)
Cochin Hospital, Paris, France
Wed 12 10:05
S6.3
Prognostication in adrenocortical carcinoma
University of Birmingham, Birmingham, United Kingdom
Wed 12 14:50
FN1.1
Wed 12 15:50
FN1.3
Spotting the chaff in the wheat: paper mills and more
Newcastle University, Newcastle, UK
Wed 12 14:50
HDI2.1
How do I manage thyroid pathology after irradiation for other head and neck cancers?
Royal Marsden Hospitals, London, UK
Wed 12 15:05
HDI2.2
Wed 12 15:20
HDI2.3
Wed 12 15:35
HDI2.4
How do I investigate and manage hypophosphataemia without hyperparathyroidism?
Newcastle, UK
Wed 12 15:50
HDI2.5
How do I manage thromboprophylaxis in Cushings?
Oxford Centre for Diabetes and Endocrinology , Oxford, UK
0 result(s) found.